Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity

被引:35
|
作者
Lu, Meng-Chen [1 ,2 ,3 ]
Zhang, Xian [1 ,2 ,3 ]
Wu, Feng [1 ,2 ]
Tan, Shi-Jie [1 ,2 ]
Zhao, Jing [1 ,2 ]
You, Qi-Dong [1 ,2 ,3 ]
Jiang, Zheng-Yu [1 ,2 ,3 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Jiang Su Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
TRANSCRIPTION FACTOR NRF2; PEPTIDE INHIBITORS; BINDING; DESIGN; TARGET; SENSOR;
D O I
10.1021/acs.jmedchem.9b00818
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The transcription factor Nrf2 is a key regulator of cytoprotective system, and enhancing Nrf2 activity can protect cells from various insults and threats. Directly disrupting Keap1-Nrf2 protein-protein interactions has been regarded as a promising way to activate Nrf2. We reported here the first identification of amino acids as preferred substituents to design potent Keap1-Nrf2 inhibitors. Comprehensive structure-activity analysis identified Pro as a preferred substituent, obtaining a potent inhibitor 35 with an IC50 of 43 nM in the competitive fluoresce polarization (FP) assay and a K-d value of 53.7 nM for Keap1 protein in the isothermal titration calorimetry (ITC) assay. The Pro analogue 35 exhibited tight and prolonged Keap1 binding in vitro and in cells, and treatment with 35 activated Nrf2-regulated cytoprotective response and antagonized acetaminophen-induced liver injury both in cellular and in vivo models. This work not only provides a useful tool to further explore the therapeutic potential of Keap1-Nrf2 inhibition but also enriches the diversity of chemical structures suitable for the Keap1-Nrf2 interface.
引用
收藏
页码:6796 / 6813
页数:18
相关论文
共 50 条
  • [1] Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors
    Zhao, Ziquan
    Dong, Ruitian
    You, Qidong
    Jiang, Zhengyu
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) : 9325 - 9344
  • [2] Discovery of β-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) protein-protein interaction inhibitors for ulcerative colitis management
    Zhao, Ziquan
    Lu, Hongjin
    Wang, Junjie
    Wu, Tingting
    Xu, Shicheng
    Ge, Yuxin
    You, Qidong
    Jiang, Zhengyu
    Lu, Mengchen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 288
  • [3] ZJ01, a Small Molecule Inhibitor of the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction, Reduces Hyperoxic Acute Lung Injury in a Mouse Model
    Wan, Jun
    Lin, Shaoyan
    Huang, Xiuling
    Li, Qianqin
    Zeng, Lingjun
    Du, Songlin
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [4] Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions
    Jiang, Zheng-Yu
    Lu, Meng-Chen
    You, Qi-Dong
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) : 10837 - 10858
  • [5] Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)
    Zhong, Mengqi
    Lynch, Andrew
    Muellers, Samantha N.
    Jehle, Stefan
    Luo, Lingqi
    Hall, David R.
    Iwase, Reina
    Carolan, James P.
    Egbert, Megan
    Wakefield, Amanda
    Streu, Kristina
    Harvey, Christine M.
    Ortet, Paula C.
    Kozakov, Dima
    Vajda, Sandor
    Allen, Karen N.
    Whitty, Adrian
    BIOCHEMISTRY, 2020, 59 (04) : 563 - 581
  • [6] Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability
    Lazzara, Phillip R.
    David, Brian P.
    Ankireddy, Aparna
    Richardson, Benjamin G.
    Dye, Katherine
    Ratia, Kiira M.
    Reddy, Sekhar P.
    Moore, Terry W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (12) : 6547 - 6560
  • [7] Design, Synthesis, and Structure-Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors
    Zhou, Hai-Shan
    Hu, Lv-Bin
    Zhang, Han
    Shan, Wen-Xin
    Wang, Yan
    Li, Xue
    Liu, Tian
    Zhao, Jing
    You, Qi-Dong
    Jiang, Zheng-Yu
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11149 - 11168
  • [8] Psoralen and Isopsoralen Activate Nuclear Factor Erythroid 2-Related Factor 2 Through Interaction With Kelch-Like ECH-Associated Protein 1
    Lv, Chengyu
    Wang, Song
    Sun, Chang
    Liu, Jing
    Chen, Yihao
    Wang, Chao
    Yuan, Cuiping
    Qin, Fengxian
    Li, Tiezhu
    FOOD SCIENCE & NUTRITION, 2025, 13 (01):
  • [9] Lapatinib Activates the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in HepG2 Cells
    Roos, Noemi Johanna
    Aliu, Diell
    Bouitbir, Jamal
    Krahenbuhl, Stephan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction
    Norton, David
    Bonnette, William G.
    Callahan, James F.
    Carr, Maria G.
    Griffiths-Jones, Charlotte M.
    Heightman, Tom D.
    Kerns, Jeffrey K.
    Nie, Hong
    Rich, Sharna J.
    Richardson, Caroline
    Rumsey, William
    Sanchez, Yolanda
    Verdonk, Marcel L.
    Willems, Henriette M. G.
    Wixted, William E.
    Wolfe, Lawrence, III
    Woolford, Alison J-A
    Wu, Zining
    Davies, Thomas G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 15949 - 15972